Long-Term Survival, Vascular Occlusive Events and Efficacy Biomarkers of First-Line Treatment of CML: A Meta-Analysis

Large randomized clinical trials and prior meta-analyses indicate that second-generation BCR-ABL tyrosine kinase inhibitors (TKIs) improve surrogate biomarkers in patients with chronic myeloid leukemia (CML) without providing survival benefits. The objective is to evaluate the long-term efficacy and...

Descripción completa

Detalles Bibliográficos
Autores principales: Haguet, Hélène, Graux, Carlos, Mullier, François, Dogné, Jean-Michel, Douxfils, Jonathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281573/
https://www.ncbi.nlm.nih.gov/pubmed/32429056
http://dx.doi.org/10.3390/cancers12051242

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281573/
https://www.ncbi.nlm.nih.gov/pubmed/32429056
http://dx.doi.org/10.3390/cancers12051242

Ejemplares similares